# Bipolar Disorder as a Product of Inflammation: Dietary Approaches to Treatment

## Abstract

Bipolar disorder (BD) is a complex psychiatric condition traditionally treated with mood stabilizers, antipsychotics, and psychotherapy. However, emerging evidence suggests significant inflammatory underpinnings in BD pathophysiology. This paper comprehensively examines the inflammatory hypothesis of bipolar disorder and evaluates dietary interventions as potential adjunctive treatment strategies. Current research indicates that bipolar disorder is associated with elevated pro-inflammatory cytokines, microglial activation, and systemic inflammation markers. Notably, these inflammatory patterns correlate with mood episode severity, cognitive dysfunction, and treatment resistance. Specific dietary patterns—particularly anti-inflammatory, Mediterranean, and ketogenic diets—show promise in modulating inflammatory pathways implicated in BD. This review synthesizes current evidence on inflammatory mechanisms in bipolar disorder and provides evidence-based recommendations for dietary interventions that may complement conventional treatment approaches.

**Keywords**: Bipolar disorder, neuroinflammation, cytokines, dietary intervention, Mediterranean diet, ketogenic diet, omega-3 fatty acids, gut-brain axis

## 1. Introduction

Bipolar disorder affects approximately 2.4% of the global population and represents a significant cause of disability worldwide (GBD 2019 Diseases and Injuries Collaborators, 2020). Despite advances in pharmacological treatments, many patients continue to experience suboptimal outcomes, with high rates of relapse, residual symptoms, and medication side effects (Vieta et al., 2018). This treatment gap has fueled interest in understanding the underlying biology of BD beyond monoamine dysregulation, with inflammation emerging as a promising avenue of investigation.

The inflammatory hypothesis of bipolar disorder posits that immune system dysregulation and chronic low-grade inflammation contribute significantly to disease pathophysiology (Rosenblat & McIntyre, 2016). This paradigm shift offers new therapeutic targets and opens the door to integrative treatment approaches, including dietary modifications that may modulate inflammatory pathways.

This paper examines the bi-directional relationship between inflammation and bipolar disorder, explores the mechanisms through which diet influences neuroinflammation, and evaluates the evidence for specific dietary interventions in bipolar disorder management. By synthesizing current research on this relationship, we aim to provide a foundation for developing evidence-based nutritional recommendations as complementary approaches to conventional BD treatment.

## 2. Inflammatory Mechanisms in Bipolar Disorder

### 2.1 Cytokine Abnormalities

Multiple meta-analyses have demonstrated altered cytokine profiles in BD patients compared to healthy controls. Specifically, pro-inflammatory cytokines including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-1 beta (IL-1β) are consistently elevated in BD, particularly during acute mood episodes (Munkholm et al., 2013; Modabbernia et al., 2013).

Goldsmith et al. (2016) conducted a comprehensive meta-analysis of 13 studies involving 556 bipolar patients and 767 healthy controls, finding significantly elevated levels of IL-6, TNF-α, soluble IL-2 receptor, and IL-1 receptor antagonist across all mood states, with particularly pronounced elevations during mania. These inflammatory markers appear to normalize partially, but not completely, during euthymia, suggesting persistent inflammatory dysregulation even between acute episodes.

### 2.2 Microglial Activation

Microglia, the brain's resident immune cells, show evidence of activation in bipolar disorder. Postmortem studies have revealed increased microglial density and morphological changes indicative of activation in the frontal cortex, hippocampus, and amygdala of BD patients (Haarman et al., 2014). Positron emission tomography (PET) studies using translocator protein (TSPO) tracers have provided in vivo evidence of microglial activation, particularly during mood episodes (Yirmiya et al., 2015).

This microglial activation contributes to neuroinflammation through several mechanisms, including:
- Release of pro-inflammatory cytokines
- Production of reactive oxygen species
- Alterations in glutamate metabolism
- Disruption of neuroplasticity and neurogenesis

### 2.3 Gut-Brain Axis Dysfunction

Mounting evidence suggests that gut microbiota dysbiosis contributes to the pathophysiology of bipolar disorder through the gut-brain axis (Dickerson et al., 2017). The gut microbiome influences systemic inflammation through:

1. Regulation of intestinal permeability
2. Production of inflammatory mediators
3. Modulation of the hypothalamic-pituitary-adrenal (HPA) axis
4. Direct vagal nerve signaling

Studies comparing the gut microbiome composition of BD patients to healthy controls have found significant differences, including reduced microbial diversity and altered abundance of specific bacterial taxa related to inflammatory processes (Evans et al., 2017). These alterations correlate with symptom severity and inflammatory marker levels, suggesting a potential causal relationship.

### 2.4 Oxidative Stress and Mitochondrial Dysfunction

Bipolar disorder is characterized by increased oxidative stress markers and mitochondrial abnormalities that contribute to and are exacerbated by inflammatory processes (Brown et al., 2014). Evidence includes:

- Elevated levels of lipid peroxidation products
- Reduced antioxidant enzyme activity
- Mitochondrial DNA (mtDNA) damage
- Impaired electron transport chain function

These factors create a self-perpetuating cycle of cellular damage, energy impairment, and inflammatory activation that may underlie the progressive nature of bipolar disorder, including cognitive decline and treatment resistance observed in some patients (Andreazza et al., 2008).

## 3. Diet as a Modulator of Inflammation in Bipolar Disorder

### 3.1 Dietary Patterns and Inflammation

Diet represents a modifiable environmental factor with substantial impact on inflammatory processes. Western dietary patterns characterized by high consumption of processed foods, refined carbohydrates, and saturated fats are associated with increased inflammatory markers and higher rates of mood disorders (Jacka et al., 2017). Conversely, traditional diets rich in vegetables, fruits, whole grains, and omega-3 fatty acids demonstrate anti-inflammatory effects and correlate with lower prevalence of psychiatric conditions.

Several dietary patterns have shown particular promise in reducing inflammation relevant to BD:

#### 3.1.1 Mediterranean Diet

The Mediterranean diet, characterized by high intake of fruits, vegetables, whole grains, olive oil, nuts, and moderate consumption of fish, has consistently shown anti-inflammatory effects. Adherence to this dietary pattern is associated with:

- Reduced levels of IL-6, TNF-α, and C-reactive protein (CRP)
- Lower oxidative stress markers
- Improved endothelial function
- Enhanced microbiome diversity

A systematic review by Lassale et al. (2019) found that greater adherence to Mediterranean diet was associated with a 33% reduced risk of depression, potentially through anti-inflammatory mechanisms.

#### 3.1.2 Anti-inflammatory Diet

The anti-inflammatory diet, similar to the Mediterranean pattern but with additional emphasis on antioxidant-rich foods and elimination of potential inflammatory triggers, has shown benefits in inflammatory conditions. Components include:

- Polyphenol-rich berries and dark-colored fruits
- Cruciferous vegetables (broccoli, kale, Brussels sprouts)
- Omega-3 rich fish and plant sources
- Turmeric, ginger, and other anti-inflammatory spices
- Reduced refined carbohydrates and processed foods

A randomized controlled trial by Agarwal et al. (2015) demonstrated that a 12-week anti-inflammatory diet intervention significantly reduced inflammatory markers in adults with metabolic syndrome, a condition frequently comorbid with bipolar disorder.

#### 3.1.3 Ketogenic Diet

The ketogenic diet (KD), characterized by very low carbohydrate and high fat intake, induces a metabolic state of ketosis that appears to have anti-inflammatory and neuroprotective effects. Emerging evidence suggests potential benefits in neuropsychiatric conditions through:

- Inhibition of NLRP3 inflammasome activation
- Reduction in pro-inflammatory cytokine production
- Enhancement of mitochondrial function
- Increased GABA/glutamate ratio in the brain

Case reports and small studies have documented mood stabilization effects of ketogenic diets in bipolar disorder (Campbell & Campbell, 2019; El-Mallakh & Paskitti, 2001), though larger controlled trials are needed.

### 3.2 Specific Dietary Components with Relevance to Bipolar Disorder

#### 3.2.1 Omega-3 Fatty Acids

Omega-3 polyunsaturated fatty acids (n-3 PUFAs), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), exert anti-inflammatory effects through:

- Competitive inhibition of arachidonic acid metabolism
- Production of specialized pro-resolving mediators (SPMs)
- Modulation of inflammatory gene expression
- Reduction in microglial activation

A meta-analysis of 638 patients with bipolar disorder by Sarris et al. (2012) found modest beneficial effects of omega-3 supplementation on depressive but not manic symptoms. The most robust evidence supports EPA-predominant formulations at doses of 1-2g/day.

#### 3.2.2 Polyphenols

Dietary polyphenols found in fruits, vegetables, tea, coffee, and cocoa have demonstrated anti-inflammatory and neuroprotective properties through:

- NF-κB pathway inhibition
- Reduction in pro-inflammatory cytokine production
- Antioxidant activity
- BDNF enhancement

Specific polyphenols showing promise in neuropsychiatric applications include resveratrol, curcumin, quercetin, and epigallocatechin gallate (EGCG). A randomized controlled trial by Lopresti et al. (2014) found that curcumin supplementation significantly reduced depressive symptoms compared to placebo, with effects comparable to antidepressant medications.

#### 3.2.3 Prebiotics and Probiotics

Prebiotic fibers and probiotic microorganisms may improve bipolar symptoms through modulation of the gut-brain axis and reduction in systemic inflammation. Mechanisms include:

- Enhancement of microbial diversity
- Improvement in intestinal barrier function
- Production of short-chain fatty acids (SCFAs)
- Modulation of tryptophan metabolism

A pilot study by Dickerson et al. (2018) found that probiotic supplementation with Lactobacillus and Bifidobacterium strains reduced hospitalization rates and improved symptom severity in patients with bipolar disorder over a 24-week period.

#### 3.2.4 Vitamin D

Vitamin D deficiency is prevalent in bipolar disorder and correlates with symptom severity (Belzeaux et al., 2018). Beyond its well-known role in calcium homeostasis, vitamin D functions as an immunomodulator, reducing inflammatory cytokine production and enhancing regulatory T cell function. Supplementation trials in bipolar disorder have shown mixed results, suggesting that vitamin D may be most beneficial in deficient individuals.

## 4. Clinical Applications and Recommendations

### 4.1 Screening for Inflammatory Markers

Given the heterogeneity of bipolar disorder, identifying patients with elevated inflammatory markers may help select individuals most likely to benefit from anti-inflammatory dietary interventions. Recommended screening parameters include:

- High-sensitivity C-reactive protein (hs-CRP)
- Inflammatory cytokines (IL-6, TNF-α)
- Markers of oxidative stress
- Assessment for inflammatory comorbidities

Patients with hs-CRP >3 mg/L may be particularly suitable candidates for anti-inflammatory approaches (Raison et al., 2013).

### 4.2 Dietary Recommendations

Based on current evidence, the following dietary strategies may be recommended as adjunctive treatments for bipolar disorder:

#### 4.2.1 Mediterranean-Style Anti-inflammatory Diet

- Abundant plant foods (vegetables, fruits, whole grains, legumes)
- Liberal use of extra virgin olive oil
- Regular consumption of fatty fish (2-3 times weekly)
- Moderate intake of fermented dairy products
- Limited red meat and processed foods
- Spices with anti-inflammatory properties (turmeric, ginger, cinnamon)

#### 4.2.2 Targeted Supplementation

- Omega-3 fatty acids: 1-2g EPA daily (with smaller amounts of DHA)
- Vitamin D: 2000-4000 IU daily for deficient individuals
- Probiotics: Multi-strain formulations including Lactobacillus and Bifidobacterium species
- N-acetylcysteine: 2000mg daily (supports glutathione production and reduces oxidative stress)

### 4.3 Implementation Strategies

Dietary modifications should be implemented with consideration of:

1. **Individual preferences and cultural factors** to enhance adherence
2. **Medication interactions** (e.g., foods affecting lithium levels)
3. **Metabolic comorbidities** often present in bipolar patients
4. **Socioeconomic barriers** to obtaining nutritious foods
5. **Mood state considerations** (appetite changes during episodes)

A collaborative approach involving psychiatrists, dietitians, and other healthcare providers optimizes outcomes. Gradual implementation with regular monitoring may improve adherence and minimize risk of adverse effects.

### 4.4 Integration with Conventional Treatments

Dietary interventions should complement rather than replace evidence-based pharmacotherapy and psychotherapy for bipolar disorder. Potential integration approaches include:

- Adding anti-inflammatory diet as adjunctive treatment to medication
- Using dietary approaches to address medication side effects
- Implementing dietary strategies during remission to potentially prevent relapses
- Considering higher intensity dietary interventions for treatment-resistant cases

## 5. Research Gaps and Future Directions

Despite promising evidence, several critical research gaps remain:

1. **Large-scale RCTs** specifically examining anti-inflammatory diets in bipolar disorder
2. **Biomarker identification** to predict response to dietary interventions
3. **Long-term adherence studies** addressing sustainability of dietary changes
4. **Personalized nutrition approaches** accounting for genetic and microbiome variations
5. **Mechanisms research** clarifying the precise pathways through which diet influences mood stability

Future research should address these gaps while exploring novel areas including:

- The role of intermittent fasting in modulating inflammatory pathways relevant to BD
- Time-restricted eating and circadian rhythm synchronization
- Precision nutrition approaches based on inflammatory endophenotypes
- Combined dietary and physical activity interventions
- Digital health technologies to support dietary adherence

## 6. Conclusion

Accumulating evidence supports the inflammatory hypothesis of bipolar disorder and suggests that dietary interventions targeting inflammatory pathways represent promising adjunctive treatment strategies. While not replacing conventional pharmacotherapy, anti-inflammatory diets—particularly Mediterranean-style patterns rich in omega-3 fatty acids, polyphenols, and fermented foods—may reduce systemic inflammation and potentially improve both psychiatric symptoms and physical comorbidities in bipolar disorder.

The bidirectional relationship between diet, inflammation, and mood underscores the importance of nutritional considerations in comprehensive bipolar disorder treatment. By addressing modifiable lifestyle factors, clinicians can expand the therapeutic toolkit available to patients and potentially improve outcomes in this challenging condition. However, further research through rigorous controlled trials is needed to establish optimal dietary protocols, identify responsive patient subgroups, and elucidate underlying mechanisms.

## References

Agarwal, S., Reider, C., Brooks, J. R., & Fulgoni, V. L. (2015). Comparison of prevalence of inadequate nutrient intake based on body weight status of adults in the United States: an analysis of NHANES 2001-2008. Journal of the American College of Nutrition, 34(2), 126-134.

Andreazza, A. C., Kauer-Sant'Anna, M., Frey, B. N., Bond, D. J., Kapczinski, F., Young, L. T., & Yatham, L. N. (2008). Oxidative stress markers in bipolar disorder: a meta-analysis. Journal of Affective Disorders, 111(2-3), 135-144.

Belzeaux, R., Annweiler, C., Bertrand, J. A., Beauchet, O., Pichet, S., Jollant, F., Turecki, G., Richard-Devantoy, S. (2018). Association between hypovitaminosis D and cognitive inhibition impairment during major depression episode. Journal of Affective Disorders, 225, 302-305.

Brown, N. C., Andreazza, A. C., & Young, L. T. (2014). An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Research, 218(1-2), 61-68.

Campbell, I. H., & Campbell, H. (2019). Ketogenic diet and bipolar disorder: A case report. Psychiatric Times, 36(3), 1-4.

Dickerson, F., Severance, E., & Yolken, R. (2017). The microbiome, immunity, and schizophrenia and bipolar disorder. Brain, Behavior, and Immunity, 62, 46-52.

Dickerson, F., Stallings, C., Origoni, A., Vaughan, C., Khushalani, S., Leister, F., Yang, S., Krivogorsky, B., Alaedini, A., & Yolken, R. (2018). Adjunctive probiotic microorganisms to prevent rehospitalization in patients with acute mania: A randomized controlled trial. Bipolar Disorders, 20(7), 614-621.

El-Mallakh, R. S., & Paskitti, M. E. (2001). The ketogenic diet may have mood-stabilizing properties. Medical Hypotheses, 57(6), 724-726.

Evans, S. J., Bassis, C. M., Hein, R., Assari, S., Flowers, S. A., Kelly, M. B., Young, V. B., Ellingrod, V. E., & McInnis, M. G. (2017). The gut microbiome composition associates with bipolar disorder and illness severity. Journal of Psychiatric Research, 87, 23-29.

GBD 2019 Diseases and Injuries Collaborators. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 396(10258), 1204-1222.

Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016). A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Molecular Psychiatry, 21(12), 1696-1709.

Haarman, B. C., Riemersma-Van der Lek, R. F., de Groot, J. C., Ruhe, H. G., Klein, H. C., Zandstra, T. E., Burger, H., Schoevers, R. A., de Vries, E. F., Drexhage, H. A., Nolen, W. A., & Doorduin, J. (2014). Neuroinflammation in bipolar disorder - A [(11)C]-(R)-PK11195 positron emission tomography study. Brain, Behavior, and Immunity, 40, 219-225.

Jacka, F. N., O'Neil, A., Opie, R., Itsiopoulos, C., Cotton, S., Mohebbi, M., Castle, D., Dash, S., Mihalopoulos, C., Chatterton, M. L., Brazionis, L., Dean, O. M., Hodge, A. M., & Berk, M. (2017). A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial). BMC Medicine, 15(1), 23.

Lassale, C., Batty, G. D., Baghdadli, A., Jacka, F., Sánchez-Villegas, A., Kivimäki, M., & Akbaraly, T. (2019). Healthy dietary indices and risk of depressive outcomes: a systematic review and meta-analysis of observational studies. Molecular Psychiatry, 24(7), 965-986.

Lopresti, A. L., Maes, M., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014). Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. Journal of Affective Disorders, 167, 368-375.

Modabbernia, A., Taslimi, S., Brietzke, E., & Ashrafi, M. (2013). Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biological Psychiatry, 74(1), 15-25.

Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013). Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. Journal of Psychiatric Research, 47(9), 1119-1133.

Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013). A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry, 70(1), 31-41.

Rosenblat, J. D., & McIntyre, R. S. (2016). Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications. Brain Sciences, 6(4), 41.

Sarris, J., Mischoulon, D., & Schweitzer, I. (2012). Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. Journal of Clinical Psychiatry, 73(1), 81-86.

Vieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018). Bipolar disorders. Nature Reviews Disease Primers, 4, 18008.

Yirmiya, R., Rimmerman, N., & Reshef, R. (2015). Depression as a microglial disease. Trends in Neurosciences, 38(10), 637-658.
